Edition:
United Kingdom

People: Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

6,510JPY
4:33am BST
Change (% chg)

¥31 (+0.48%)
Prev Close
¥6,479
Open
¥6,453
Day's High
¥6,540
Day's Low
¥6,437
Volume
417,900
Avg. Vol
1,091,944
52-wk High
¥11,490
52-wk Low
¥6,040

Kai, Yasunobu 

Mr. Yasunobu Kai has been serving as Executive Officer, Chief Planning Officer of Oncology Business Group and Director of Planning of Oncology Business Group in Eisai Co., Ltd. since June 2018. He joined the Company in April 1986. His previous titles include President of Frontier Drug Development Unit and President of Eisai Value Maximization Systems in the Company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --